Page last updated: 2024-11-01

olprinone and Alloxan Diabetes

olprinone has been researched along with Alloxan Diabetes in 1 studies

olprinone: RN refers to HCl; structure given in first source

Research Excerpts

ExcerptRelevanceReference
"The authors examined whether olprinone, a phosphodiesterase type 3 inhibitor, or isoflurane, a volatile anesthetic, could protect the heart against myocardial infarction in type 2 diabetic rats and whether the underlying mechanisms involve protein kinase C (PKC), mitochondrial ATP-sensitive potassium (m-K(ATP)) channels, or the phosphatidylinositol 3-kinase (PI3K)-Akt pathway."3.75Pharmacological preconditioning in type 2 diabetic rat hearts: the roles of mitochondrial ATP-sensitive potassium channels and the phosphatidylinositol 3-kinase-Akt pathway. ( Cho, S; Hara, T; Maekawa, T; Matsumoto, S; Sumikawa, K; Tosaka, S; Ureshino, H, 2009)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Matsumoto, S1
Cho, S1
Tosaka, S1
Ureshino, H1
Maekawa, T1
Hara, T1
Sumikawa, K1

Other Studies

1 other study available for olprinone and Alloxan Diabetes

ArticleYear
Pharmacological preconditioning in type 2 diabetic rat hearts: the roles of mitochondrial ATP-sensitive potassium channels and the phosphatidylinositol 3-kinase-Akt pathway.
    Cardiovascular drugs and therapy, 2009, Volume: 23, Issue:4

    Topics: Anesthetics, Inhalation; Animals; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Imidaz

2009